Xcout IntelSign inSubscribe

Haleon competitors & alternatives

HLNPharmaceuticalsWeybridge, United Kingdom

The 12 closest competitors and alternatives to Haleon among pharmaceuticals companies — ranked by similarity to what Haleon actually does, not by market-cap band.

$42.7BMarket cap
24,535Employees
12Competitors listed

Subscribe to see Haleon’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Haleon

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

Haleon at a glance

Haleon is a pharmaceuticals company headquartered in Weybridge, United Kingdom, founded in 2021. It is publicly listed (HLN) with a market capitalisation of $42.7B. Xcout tracks 10 named people at Haleon, including Brian James McNamara (Chief Executive Officer & Executive Director). Xcout recorded 300 job postings from Haleon in the last 90 days, naming tools such as SAP.

Haleon leadership

  • Brian James McNamaraChief Executive Officer & Executive Director
  • Filippo LanziPresident of EMEA & LatAm
  • Keith ChoyPresident of Asia Pacific
  • Dawn Amanda AllenChief Financial Officer & Director
  • Claire DicksonChief Digital & Technology Officer
  • Line De DeckerChief Human Resources Officer

4 more named people on record for Haleon, with roles, board committees and tenure — see the full roster →

Hiring at Haleon

Xcout recorded 300 job postings from Haleon in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Haleon's job postings

SAP

The weekly hiring trend, the roles and locations behind it — see Haleon's hiring signals →

Top 12 Haleon competitors

Ranked by semantic similarity — how close each company is to Haleon by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Cardinal Health0HTG · PharmaceuticalsDublin, United States
61% matchPublic

Similar pharmaceuticals company

Cardinal Health, Inc. functions as a comprehensive provider of healthcare services and products, extending its reach across the United States, Canada, Europe, Asia, and other international markets. The company delivers tailored solutions to a diverse client base, encompassing hospitals, healthcare systems, pharmacies, outpatient surgical centers, clinical testing facilities, physician's offices, and individuals receiving care at home. Its operations are bifurcated into two principal divisions: Pharmaceutical and Medical. The Pharmaceutical division is responsible for the distribution of a broad spectrum of pharmaceuticals, including proprietary and generic medications, specialty drugs, and over-the-counter health items. It further extends its services to pharmaceutical manufacturers and healthcare providers, specifically supporting specialized pharmaceutical products. This segment also manages nuclear pharmacies and facilities for radiopharmaceutical production, in addition to repackaging generic and OTC health products. Moreover, it delivers medication therapy management and patient outcomes improvement services to hospitals, various healthcare practitioners, and insurers, alongside providing comprehensive pharmacy management for hospitals. The Medical division concentrates on the manufacturing, procurement, and distribution of Cardinal Health's proprietary range of medical, surgical, and laboratory equipment and supplies. This extensive product portfolio features items such as examination and surgical gloves; needles, syringes, and sharps disposal units; compression wear; incontinence supplies; nutritional delivery systems; wound care products; single-use surgical drapes, gowns, and apparel; fluid suction and collection apparatus; urological supplies; operating room essentials; and electrode product lines. Furthermore, this segment distributes a wide array of nationally recognized medical, surgical, and laboratory products. It also offers critical supply chain services and solutions to hospitals, outpatient surgical centers, clinical laboratories, and other healthcare providers, while also producing and selling pre-assembled sterile and non-sterile procedure kits. Established in 1979, Cardinal Health maintains its corporate headquarters in Dublin, Ohio.

Market cap$54.4B
Employees47,922
Cardinal Health competitors & alternatives →
CencoraCOR · HealthcareConshohocken, United States
62% matchPublic

Healthcare

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Market cap$59.9B
Employees51,000
Cencora competitors & alternatives →
Perrigo Company plc0Y5E · PharmaceuticalsDublin, Ireland
71% matchPublic

Similar pharmaceuticals company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Market cap$1.8B
Employees8,100
Perrigo Company plc competitors & alternatives →
Bausch Health Companies Inc.BHC · PharmaceuticalsLaval, Canada
66% matchPublic

Similar pharmaceuticals company

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.

Market cap$1.8B
Employees20,300
Bausch Health Companies Inc. competitors & alternatives →
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited600332 · PharmaceuticalsGuangzhou, China
64% matchPublic

Similar pharmaceuticals company

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL), along with its various subsidiaries, operates as a comprehensive pharmaceutical enterprise. It is actively engaged in the research, development, production, and distribution of a wide array of products, including traditional Chinese patent medicines, Western pharmaceuticals, chemical raw materials, natural and biological medications, and chemical raw material intermediates. Its operations span both the People's Republic of China and international markets. The company structures its extensive operations into four primary segments: Great Southern TCM, Great Commerce, Great Health, and a miscellaneous 'Others' category. Beyond its core pharmaceutical manufacturing, GBPHCL's activities extend to the wholesale, retail, import, and export of both Western and traditional Chinese medicines, as well as medical apparatus and instruments. Furthermore, its diverse product portfolio encompasses the research, development, production, and sale of consumer health items such as beverages, various food products (including pre-packaged items and dairy), and a broad range of pharmaceutical formulations like tablets, capsules, lozenges, injections, and even traditional specialties like tortoise herb jelly. The group also strategically invests in the broader health industry, focusing on areas like medical care, health management, health preservation, and elderly care. Complementing these activities, it offers commercial and advertising services. As of December 31, 2021, GBPHCL maintained a substantial retail presence, operating 154 chain pharmacy outlets. This network comprised 22 Cai Zhi Lin pharmacies, 36 Jian Min pharmacies, 51 GPC Prescription Pharmacy locations, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd. outlets, alongside an additional 22 general retail stores. Tracing its origins back to its incorporation in 1997, the company was initially known as Guangzhou Pharmaceutical Company Limited. It adopted its current name, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, in August 2013. The company is headquartered in Guangzhou, China.

Market cap$5.1B
Employees27,057
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited competitors & alternatives →
BAIYUNSHAN PH00874 · PharmaceuticalsChina
63% matchPublic

Similar pharmaceuticals company

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL) is a comprehensive pharmaceutical enterprise focused on the research, development, production, and distribution of a wide array of medical products. These offerings span traditional Chinese patent medicines, Western pharmaceuticals, chemical raw materials and their intermediates, alongside natural and biological remedies, serving both the Chinese domestic market and international clientele. The company's operations are strategically divided into four primary segments: Great Southern TCM, Great Commerce, Great Health, and Others. Beyond its manufacturing activities, GBPHCL is actively involved in the import, export, wholesale, and retail of both Western and Chinese medicines, as well as medical equipment. The company also develops, manufactures, and sells various consumer goods including beverages, food products, health supplements, pre-packaged foods, dairy items, and diverse pharmaceutical forms such as tablets, capsules, lozenges, and injections, in addition to traditional items like tortoise herb jelly. Furthermore, GBPHCL makes strategic investments in the broader health industry, covering areas like medical services, health management, wellness initiatives, and elderly care. It also provides commercial and advertising solutions. As of December 31, 2021, the company maintained a substantial retail presence, managing 154 chain pharmacies operating under brands like Cai Zhi Lin, Jian Min, GPC Prescription Pharmacy, and Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd, supplemented by an additional 22 independent retail stores. Established in 1997, the company originally operated as Guangzhou Pharmaceutical Company Limited before adopting its current name, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, in August 2013. Its headquarters are situated in Guangzhou, China.

Market cap$4.8B
Employees27,057
BAIYUNSHAN PH competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Haleon and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Haleonand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →